Genexine Investor

Genexine is a clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics.

Invests into

Technology: Artificial Intelligence, Biotechnology, Cell_Therapies, Medical
Industry: Healthcare
Headquarters: Seongnam, Kyonggi-do, South Korea
Founded Date: 1999-06-08
Employees Number: 101-250
Number Of Exits: 1
Estimated Revenue: $10M to $50M

Visit Website
recruit@genexine.com
Register and Claim Ownership